Advancement in magnetic hyperthermia-based targeted therapy for cancer treatment
Biointerphases · 2023
DOI: 10.1116/6.0003079 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biointerphases, 2023. Verfasst von Neha Srivastava und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, India. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Neoplasms, Magnetite Nanoparticles. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 129 Literaturangaben.
Abstract (Originalsprache)
Magnetic hyperthermia utilizing magnetic nanoparticles (MNPs) and an alternating magnetic field (AMF) represents a promising approach in the field of cancer treatment. Active targeting has emerged as a valuable strategy to enhance the effectiveness and specificity of drug delivery. Active targeting utilizes specific biomarkers that are predominantly found in abundance on cancer cells while being minimally expressed on healthy cells. Current comprehensive review provides an overview of several cancer-specific biomarkers, including human epidermal growth factor, transferrin, folate, luteinizing hormone-releasing hormone, integrin, cluster of differentiation (CD) receptors such as CD90, CD95, CD133, CD20, and CD44 also CXCR4 and vascular endothelial growth factor, these biomarkers bind to ligands present on the surface of MNPs, enabling precise targeting. Additionally, this review touches various combination therapies employed to combat cancer. Magnetic hyperthermia synergistically enhances the efficacy of conventional cancer treatments such as targeted chemotherapy, radiation therapy, gene therapy, and immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Thapar Institute of Engineering and Technology, Patiala 147004, India.
- School of Physics and Materials Science, Thapar Institute of Engineering and Technology, Patiala 147004, India.
ORCID-Profile: Neha Srivastava
Zitieren
APA
Srivastava, N., Chudasama, B., & Baranwal, M. (2023). Advancement in magnetic hyperthermia-based targeted therapy for cancer treatment. Biointerphases. https://doi.org/10.1116/6.0003079
Vancouver
Srivastava N, Chudasama B, Baranwal M. Advancement in magnetic hyperthermia-based targeted therapy for cancer treatment. Biointerphases. 2023. doi:10.1116/6.0003079
BibTeX
@article{Srivastava2023,
author = {Srivastava, Neha and Chudasama, Bhupendra and Baranwal, Manoj},
title = {Advancement in magnetic hyperthermia-based targeted therapy for cancer treatment},
journal = {Biointerphases},
year = {2023},
doi = {10.1116/6.0003079}
}
EUVIMED